24.23
price up icon2.67%   0.63
after-market アフターアワーズ: 23.32 -0.91 -3.76%
loading
前日終値:
$23.60
開ける:
$23.96
24時間の取引高:
522.23K
Relative Volume:
0.71
時価総額:
$1.80B
収益:
$105.97M
当期純損益:
$-81.13M
株価収益率:
-22.45
EPS:
-1.0791
ネットキャッシュフロー:
$-35.43M
1週間 パフォーマンス:
+3.33%
1か月 パフォーマンス:
+0.46%
6か月 パフォーマンス:
+49.94%
1年 パフォーマンス:
+89.30%
1日の値動き範囲:
Value
$23.96
$24.82
1週間の範囲:
Value
$23.08
$24.82
52週間の値動き範囲:
Value
$9.03
$28.49

Zymeworks Inc. Stock (ZYME) Company Profile

Name
名前
Zymeworks Inc.
Name
セクター
Healthcare (1114)
Name
電話
604-678-1388
Name
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
Name
職員
170
Name
Twitter
@ZymeworksInc
Name
次回の収益日
2026-03-02
Name
最新のSEC提出書
Name
ZYME's Discussions on Twitter

Compare ZYME vs VRTX, REGN, ALNY, ARGX, INSM

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ZYME icon
ZYME
Zymeworks Inc.
24.23 1.75B 105.97M -81.13M -35.43M -1.0791
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
454.97 113.96B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
749.47 78.41B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
328.70 40.85B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
697.05 42.05B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
148.31 29.99B 606.42M -1.28B -997.58M -6.403

Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-12 アップグレード Wells Fargo Equal Weight → Overweight
2025-12-03 開始されました Citizens JMP Mkt Outperform
2025-10-24 再開されました Wells Fargo Equal Weight
2025-10-14 アップグレード H.C. Wainwright Neutral → Buy
2025-10-10 開始されました B. Riley Securities Buy
2025-05-20 開始されました TD Cowen Buy
2024-12-16 アップグレード JP Morgan Neutral → Overweight
2024-11-07 アップグレード Leerink Partners Market Perform → Outperform
2024-11-01 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-21 再開されました Wells Fargo Overweight
2023-01-04 繰り返されました H.C. Wainwright Neutral
2022-12-20 アップグレード Jefferies Hold → Buy
2022-11-01 ダウングレード H.C. Wainwright Buy → Neutral
2022-10-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-10-04 再開されました Wells Fargo Overweight
2022-05-05 アップグレード Guggenheim Neutral → Buy
2022-03-15 開始されました Evercore ISI Outperform
2021-12-10 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-17 再開されました Guggenheim Neutral
2021-10-07 開始されました Jefferies Hold
2021-03-31 開始されました Credit Suisse Outperform
2021-02-25 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-08 再開されました H.C. Wainwright Buy
2021-01-25 ダウングレード Citigroup Buy → Neutral
2020-09-29 再開されました JP Morgan Neutral
2020-08-06 開始されました SVB Leerink Outperform
2020-01-10 開始されました Wolfe Research Outperform
2019-12-09 開始されました JP Morgan Neutral
2019-11-25 開始されました H.C. Wainwright Buy
2019-11-20 開始されました Guggenheim Buy
2019-09-30 アップグレード Raymond James Outperform → Strong Buy
2019-08-30 開始されました Stifel Buy
2019-07-18 開始されました Deutsche Bank Buy
2018-05-11 アップグレード Barclays Underweight → Equal Weight
2018-03-19 開始されました Raymond James Outperform
すべてを表示

Zymeworks Inc. (ZYME) 最新ニュース

pulisher
Mar 25, 2026

Tranche Update on Zymeworks Inc.'s Equity Buyback Plan announced on November 18, 2025. - marketscreener.com

Mar 25, 2026
pulisher
Mar 25, 2026

Zymeworks Inc stock faces renewed scrutiny amid biotech sector volatility and pipeline updates - AD HOC NEWS

Mar 25, 2026
pulisher
Mar 25, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences - Sahm

Mar 25, 2026
pulisher
Mar 24, 2026

Aug Weekly: Does Zymeworks Inc stock have upside surprise potentialGap Up & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Mar 24, 2026
pulisher
Mar 24, 2026

Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences - TipRanks

Mar 24, 2026
pulisher
Mar 24, 2026

Zymeworks executives head to two April healthcare investor events - Stock Titan

Mar 24, 2026
pulisher
Mar 23, 2026

Published on: 2026-03-23 15:16:44 - baoquankhu1.vn

Mar 23, 2026
pulisher
Mar 21, 2026

Zymeworks Inc. (ZYME) reports Q4 loss, lags revenue estimates - MSN

Mar 21, 2026
pulisher
Mar 20, 2026

Zymeworks Inc stock faces biotech volatility amid pipeline updates and market shifts - AD HOC NEWS

Mar 20, 2026
pulisher
Mar 20, 2026

Will Zymeworks Inc benefit from rising consumer demand2026 WrapUp & Weekly Market Pulse Updates - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 18, 2026

Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach - TipRanks

Mar 18, 2026
pulisher
Mar 18, 2026

Experimental breast cancer drug shrinks tumors in 6 weeks at AACR 2026 - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Does Zymeworks (ZYME) Pan-RAS ADC Push Reveal a Durable Edge in Targeted Oncology? - Sahm

Mar 18, 2026
pulisher
Mar 18, 2026

Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting - Koreabizwire

Mar 18, 2026
pulisher
Mar 17, 2026

Zymeworks to present clinical data on cancer drug candidate at AACR - Investing.com Australia

Mar 17, 2026
pulisher
Mar 17, 2026

Zymeworks to present clinical data on cancer drug candidate at AACR By Investing.com - Investing.com South Africa

Mar 17, 2026
pulisher
Mar 17, 2026

Zymeworks Highlights ADC and Novel Pan-RAS Platform Data Ahead of AACR Meeting - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

Zymeworks to Present Clinical and Preclinical Data on ADC - GlobeNewswire

Mar 17, 2026
pulisher
Mar 17, 2026

New cancer drug conjugates aim at tough RAS tumors in Zymeworks data - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

A Look At Zymeworks (ZYME) Valuation After New AACR 2026 Antibody Drug Conjugate Pipeline Data - Sahm

Mar 17, 2026
pulisher
Mar 14, 2026

Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High? - MSN

Mar 14, 2026
pulisher
Mar 14, 2026

Prosight Management LP Cuts Stake in Zymeworks Inc. $ZYME - MarketBeat

Mar 14, 2026
pulisher
Mar 12, 2026

Value Recap: Does Zymeworks Inc have strong EBITDA marginsTrade Analysis Report & Accurate Buy Signal Notifications - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 10, 2026

Zymeworks (NASDAQ:ZYME) Trading Up 9.7%What's Next? - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Assessing Zymeworks (ZYME) Valuation After Q4 Updates And Improved Clinical And Funding Outlook - Sahm

Mar 10, 2026
pulisher
Mar 09, 2026

Zymeworks (ZYME) Price Target Raised to $48 by Evercore ISI Grou - GuruFocus

Mar 09, 2026
pulisher
Mar 08, 2026

Will Zymeworks' (ZYME) Wider Losses and ESOP Shelf Offering Recast Its Long-Term Equity Story? - Sahm

Mar 08, 2026
pulisher
Mar 06, 2026

Zymeworks (NASDAQ:ZYME) Price Target Raised to $46.00 - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Zymeworks (ZYME) Rating Maintained, Price Target Raised to $46 b - GuruFocus

Mar 06, 2026
pulisher
Mar 05, 2026

Q1 Earnings Forecast for Zymeworks Issued By Lifesci Capital - MarketBeat

Mar 05, 2026
pulisher
Mar 04, 2026

Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside (NASDAQ:ZYME) - Seeking Alpha

Mar 04, 2026
pulisher
Mar 04, 2026

Zymeworks Inc. (NASDAQ:ZYME) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Zymeworks (NASDAQ:ZYME) Trading 2.8% Higher on Analyst Upgrade - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Forecasting The Future: 4 Analyst Projections For Zymeworks - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

Zymeworks (ZYME) Target Price Raised by Leerink Partners to $58 - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Stifel raises Zymeworks stock price target on royalty deal value By Investing.com - Investing.com Canada

Mar 03, 2026
pulisher
Mar 03, 2026

Stifel raises Zymeworks stock price target on royalty deal value - Investing.com

Mar 03, 2026
pulisher
Mar 03, 2026

Zymeworks Inc. (NASDAQ:ZYME) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 03, 2026
pulisher
Mar 03, 2026

Citizens reiterates Zymeworks stock rating on strong cash position - Investing.com Nigeria

Mar 03, 2026
pulisher
Mar 03, 2026

Citizens reiterates Zymeworks stock rating on strong cash position By Investing.com - Investing.com Australia

Mar 03, 2026
pulisher
Mar 03, 2026

Zymeworks Inc (ZYME) Q4 2025 Earnings Call Highlights: Strategic Milestones and Financial Resilience By GuruFocus - Investing.com Canada

Mar 03, 2026
pulisher
Mar 03, 2026

Decoding Zymeworks Inc (ZYME): A Strategic SWOT Insight - GuruFocus

Mar 03, 2026
pulisher
Mar 02, 2026

Zymeworks secures $250M royalty financing from Royalty Pharma - Investing.com South Africa

Mar 02, 2026
pulisher
Mar 02, 2026

Zymeworks (ZYME) Advances with Promising Zanidatamab Results - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

Jefferies reiterates Zymeworks stock rating on financing deal By Investing.com - Investing.com Canada

Mar 02, 2026
pulisher
Mar 02, 2026

Jefferies reiterates Zymeworks stock rating on financing deal - Investing.com South Africa

Mar 02, 2026
pulisher
Mar 02, 2026

Zymeworks (ZYME) Reveals Q4 Revenue Drop and Strategic Focus Shi - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

Zymeworks Inc (ZYME) Q4 2025 Earnings Call Highlights: Strategic Milestones and Financial Resilience - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

Zymeworks Secures $250 Million Non-Dilutive Royalty-Backed Financing from Royalty Pharma for Ziihera Royalties - Minichart

Mar 02, 2026
pulisher
Mar 02, 2026

Zymeworks Inc. (ZYME) Posts Fourth Quarter Loss, Falls Short of Revenue Projections - Bitget

Mar 02, 2026
pulisher
Mar 02, 2026

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing - citybiz

Mar 02, 2026

Zymeworks Inc. (ZYME) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
大文字化:     |  ボリューム (24 時間):